|
|
|
|
| LEADER |
00000cam a2200000 i 4500 |
| 001 |
EBOOKCENTRAL_on1002699399 |
| 003 |
OCoLC |
| 005 |
20240329122006.0 |
| 006 |
m o d |
| 007 |
cr |n|---||||| |
| 008 |
170902s2017 nju of 000 0 eng d |
| 040 |
|
|
|a EBLCP
|b eng
|e pn
|c EBLCP
|d OCLCQ
|d MERUC
|d OCLCQ
|d UEJ
|d OCLCO
|d OCLCF
|d OCLCQ
|d OCLCO
|d OCLCQ
|d OCLCO
|d OCLCL
|
| 066 |
|
|
|c Zsym
|
| 020 |
|
|
|a 9781119220770
|
| 020 |
|
|
|a 1119220777
|
| 035 |
|
|
|a (OCoLC)1002699399
|
| 050 |
|
4 |
|a RM267
|b .S35 2017
|
| 082 |
0 |
4 |
|a 615/.329
|2 23
|
| 049 |
|
|
|a UAMI
|
| 100 |
1 |
|
|a Schlossberg, David L.
|
| 245 |
1 |
0 |
|a Antibiotics :
|b a Guide to Commonly Used Antimicrobials.
|
| 250 |
|
|
|a 2nd ed.
|
| 260 |
|
|
|a Newark :
|b John Wiley & Sons, Incorporated,
|c 2017.
|
| 300 |
|
|
|a 1 online resource (477 pages)
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 588 |
0 |
|
|a Print version record.
|
| 500 |
|
|
|a SIDE EFFECTS/TOXICITY.
|
| 590 |
|
|
|a ProQuest Ebook Central
|b Ebook Central Academic Complete
|
| 650 |
|
0 |
|a Antibiotics
|v Handbooks, manuals, etc.
|
| 650 |
|
7 |
|a Antibiotics
|2 fast
|
| 655 |
|
2 |
|a Handbook
|
| 655 |
|
7 |
|a handbooks.
|2 aat
|
| 655 |
|
7 |
|a Handbooks and manuals
|2 fast
|
| 655 |
|
7 |
|a Handbooks and manuals.
|2 lcgft
|
| 655 |
|
7 |
|a Guides et manuels.
|2 rvmgf
|
| 700 |
1 |
|
|a Samuel, Rafik.
|
| 758 |
|
|
|i has work:
|a Antibiotics (Text)
|1 https://id.oclc.org/worldcat/entity/E39PCYdxDM8pVFTKrcC3yTr7Pj
|4 https://id.oclc.org/worldcat/ontology/hasWork
|
| 776 |
0 |
8 |
|i Print version:
|a Schlossberg, David L.
|t Antibiotics : A Guide to Commonly Used Antimicrobials.
|d Newark : John Wiley & Sons, Incorporated, ©2017
|z 9781119220756
|
| 856 |
4 |
0 |
|u https://ebookcentral.uam.elogim.com/lib/uam-ebooks/detail.action?docID=4983271
|z Texto completo
|
| 880 |
0 |
|
|6 505-00/Zsym
|a TITLE PAGE ; COPYRIGHT PAGE; BRAND TABLE OF CONTENTS; GENERIC NAME; PREFACE; ■ ABELCET (Amphotericin B Lipid Complex); BASIC CHARACTERISTICS ; FDA-APPROVED INDICATIONS ; SIDE EFFECTS/TOXICITY ; DRUG INTERACTIONS ; DOSING ; SPECIAL POPULATIONS ; RENAL IMPAIRMENT ; HEPATIC IMPAIRMENT ; PEDIATRICS:; THE ART OF ANTIMICROBIAL THERAPY ; ■ ALBENZA (Albendazole); BASIC CHARACTERISTICS ; FDA-APPROVED INDICATIONS ; SIDE EFFECTS/TOXICITY ; DRUG INTERACTIONS/FOOD INTERACTIONS ; DOSING ; SPECIAL POPULATIONS ; RENAL IMPAIRMENT ; HEPATIC DYSFUNCTION ; PEDIATRICS ; THE ART OF ANTIMICROBIAL THERAPY.
|
| 880 |
8 |
|
|6 505-00/Zsym
|a ■ ALINIA (Nitazoxanide)BASIC CHARACTERISTICS ; FDA-APPROVED INDICATIONS ; SIDE EFFECTS/TOXICITY ; DRUG INTERACTIONS/FOOD INTERACTIONS ; DOSING ; SPECIAL POPULATIONS ; RENAL IMPAIRMENT ; HEPATIC DYSFUNCTION ; PEDIATRICS ; THE ART OF ANTIMICROBIAL THERAPY ; ■ AMBISOME (Liposomal Amphotericin B); BASIC CHARACTERISTICS ; FDA-APPROVED INDICATIONS ; SIDE EFFECTS/TOXICITY ; DRUG INTERACTIONS ; DOSING ; SPECIAL POPULATIONS ; RENAL IMPAIRMENT ; HEPATIC IMPAIRMENT ; PEDIATRICS ; THE ART OF ANTIMICROBIAL THERAPY ; ■ AMIKIN (Amikacin); BASIC CHARACTERISTICS ; FDA-APPROVED INDICATIONS.
|
| 880 |
8 |
|
|6 505-00/Zsym
|a SIDE EFFECTS/TOXICITY DRUG INTERACTIONS ; DOSING ; SPECIAL POPULATIONS ; RENAL IMPAIRMENT ; HEPATIC DYSFUNCTION ; PEDIATRICS ; THE ART OF ANTIMICROBIAL THERAPY ; ■ AMOXICILLIN; BASIC CHARACTERISTICS ; FDA-APPROVED INDICATIONS ; SIDE EFFECTS/TOXICITY ; DRUG INTERACTIONS/FOOD INTERACTIONS ; DOSING ; SPECIAL POPULATIONS ; RENAL IMPAIRMENT ; HEPATIC DYSFUNCTION; PEDIATRICS ; THE ART OF ANTIMICROBIAL THERAPY ; ■ AMPHOTEC (Amphotericin B Colloidal Dispersion -- ABCD); BASIC CHARACTERISTICS ; FDA-APPROVED INDICATIONS ; SIDE EFFECTS/TOXICITY ; DRUG INTERACTIONS ; DOSING ; SPECIAL POPULATIONS.
|
| 880 |
8 |
|
|6 505-00/Zsym
|a RENAL IMPAIRMENT HEPATIC IMPAIRMENT; PEDIATRICS ; THE ART OF ANTIMICROBIAL THERAPY ; ■ AMPICILLIN; BASIC CHARACTERISTICS ; FDA-APPROVED INDICATIONS ; SIDE EFFECTS/TOXICITY ; DRUG INTERACTIONS/FOOD INTERACTIONS ; DOSING ; SPECIAL POPULATIONS ; RENAL IMPAIRMENT; HEPATIC DYSFUNCTION; PEDIATRICS; THE ART OF ANTIMICROBIAL THERAPY ; ■ ANCEF (Cefazolin); BASIC CHARACTERISTICS ; FDA-APPROVED INDICATIONS ; SIDE EFFECTS/TOXICITY ; DRUG INTERACTIONS/FOOD INTERACTIONS ; DOSING ; SPECIAL POPULATIONS ; RENAL IMPAIRMENT:; HEPATIC DYSFUNCTION ; PEDIATRICS ; THE ART OF ANTIMICROBIAL THERAPY.
|
| 880 |
8 |
|
|6 505-00/Zsym
|a ■ ANCOBON (Flucytosine)BASIC CHARACTERISTICS ; FDA-APPROVED INDICATIONS ; SIDE EFFECTS/TOXICITY ; DRUG INTERACTIONS ; DOSING ; SPECIAL POPULATIONS ; HEPATIC IMPAIRMENT ; RENAL IMPAIRMENT ; PEDIATRICS ; THE ART OF ANTIMICROBIAL THERAPY ; ■ ANTIMINTH (Pyrantel Pamoate); BASIC CHARACTERISTICS ; SIDE EFFECTS/TOXICITY ; DRUG INTERACTIONS/FOOD INTERACTIONS ; DOSING ; SPECIAL POPULATIONS ; RENAL IMPAIRMENT; HEPATIC DYSFUNCTION ; PEDIATRICS; THE ART OF ANTIMICROBIAL THERAPY ; ■ ARALEN (Chloroquine Phosphate and Hydroxychloroquine); BASIC CHARACTERISTICS ; FDA-APPROVED INDICATIONS.
|
| 936 |
|
|
|a BATCHLOAD
|
| 938 |
|
|
|a EBL - Ebook Library
|b EBLB
|n EBL4983271
|
| 994 |
|
|
|a 92
|b IZTAP
|
